Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial Ko, J., Roberts, J., Hordinsky, M., Taylor, S., Mostaghimi, A., Chiasserini, C., Ding, Y., Chen, Y., Wu, W., Dutronc, Y. MOSBY-ELSEVIER. 2021: AB155

View details for Web of Science ID 000683887500604